How we connected at Melanoma March Virtual 2020
21 April 2020
We could not have asked for a better start to Melanoma March 2020 with superb events in Rockhampton and Sunshine Coast on Sunday 1 March. The following weekend a beautiful twilight gathering was held in Devonport on Saturday evening and then on Sunday inspiring events took place on the Central Coast and in Western Sydney, where participants demonstrated yet again that a bit of rain would not dampen the community spirit of Melanoma March.
After such a wonderful start it was then so disappointing when we made the decision to cancel our remaining 19 physical events, due to the escalating impact of COVID-19. We know what Melanoma March means to our community, so instead we created Melanoma March Virtual so that everyone across Australia could still come together (even if in a different way), as we have done at Melanoma March events for the last 9 years. We wanted people to still be able to honour loved ones and support each other.
It was so heart-warming to see how everyone embraced Melanoma March Virtual with enthusiasm. The creative ways in which people took steps whilst still social distancing was inspiring! Activities included bushwalking, bike-riding, backyard soccer, dog-walking, dancing, gardening, scooter-riding, stepping, horse-riding and even a morning tea party! Thank you so much to everyone who shared their pictures, videos and stories, and thank you to everyone who supported by donating over $310,000 to melanoma research. We hope, like us, everyone could feel the connection and support.
Watch the Event Welcome video below and see more of the activities on our Melanoma March Facebook or Instagram page.
Melanoma March 2020 Principal Partner is Ricky, Australia’s leading supplier of technical textiles and sun control fabrics.
Carole Renouf, CEO of Melanoma Institute Australia is asking young Australians who have been affected by melanoma to share their experiences with her.
Melanoma Institute Australia CEO Carole Renouf wants to make sure Aussies remember to take care of our skin as the festive season draws closer and we spend more time in the sun.
Can an individual’s risk factors for melanoma be used to tailor skin self-examinations and surveillance programs?
Prof Georgina Long has been appointed President-Elect Society for Melanoma Research (SMR).
The Australasian Melanoma Conference is bringing together some of the world's leading researchers and clinicians.
Best practice guidelines for melanoma care have gone digital with the first-ever online guidelines developed to adapt to the rapid change in clinical management.
Congratulations are in order for two of our talented researchers.
Professor Richard Scolyer will be sharing his expertise on melanoma pathology at the upcoming Australasian Melanoma Conference. Here he discusses what he'll be presenting on.
Researchers at MIA have established a High Risk Clinic to monitor people at very high risk of developing melanoma.
A generous donation has enabled a medical oncologist from Portugal to learn from the best in the world at MIA.
MIA is hosting a conference to bring together greats minds in melanoma research that will make a difference to the lives of melanoma patients
Meet Michelle, our Translational Research Officer whose role is to connect the clinics to the lab by ensuring patient blood and tissue samples are documented and carefully stored in our BioSpecimen Bank.
Dr James Wilmott says his Wildfire Award will help expand research into treatment options for people with mucosal melanoma, a rare but deadly form of skin cancer.
Following the recent hype around immunotherapies in cancer, CEO Carole Renouf shares the greatest story never told… resistance… and what MIA is doing to address it.
A/Prof Wargo discusses the research she will be presenting as a keynote speaker at the upcoming Australasian Melanoma Conference.
Dr James Wilmott has been awarded the Wildfire award at this year's Cancer Institute NSW's Premier Awards for Outstanding Cancer Research.
The community has responded generously to our recent appeal to fund a specialised nursing position in an exciting new clinical trial.
We have developed a unique clinical trial that will use existing drugs to target rare genes in melanoma patients.
Data presented at the recent ASCO Annual Meeting showcased advances in melanoma research, particularly long-term survival data.
We value your privacy and want you to be familiar with how we collect, use and disclose your information.